BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1673786)

  • 1. [Prevention of duodenal ulcer recurrence. A new prospect].
    Soulé JC
    Presse Med; 1991 Mar; 20(10):465-70. PubMed ID: 1673786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate.
    Bianchi Porro G; Parente F
    J Clin Gastroenterol; 1992 Apr; 14(3):192-8. PubMed ID: 1348753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN; Nio CY
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():152-61. PubMed ID: 3660894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colloidal bismuth in the treatment of duodenal ulceration: the benefit for the patient.
    Miller JP
    Scand J Gastroenterol Suppl; 1989; 157():16-20; discussion 21-2. PubMed ID: 2568684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of duodenal ulcer with sucralfate.
    Lam SK
    Scand J Gastroenterol Suppl; 1991; 185():22-8. PubMed ID: 1683491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs for treatment of peptic ulcers.
    Dajani EZ; Trotman BW
    J Assoc Acad Minor Phys; 1992; 3(3):78-88. PubMed ID: 1353999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of relapse rate on the choice of duodenal ulcer therapy.
    Drug Ther Bull; 1987 Oct; 25(20):77-80. PubMed ID: 2890508
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of colloidal bismuth subcitrate with ranitidine in healing and relapse of Campylobacter pylori-associated duodenal ulcers].
    Hu FL; Jia BQ; Gao HZ
    Zhonghua Nei Ke Za Zhi; 1990 Jun; 29(6):339-41, 382. PubMed ID: 2269032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Difficult' duodenal ulcer patients: clinical and therapeutic problems.
    Bianchi Porro G; Parente F
    Dig Dis; 1991; 9(4):219-28. PubMed ID: 1680585
    [No Abstract]   [Full Text] [Related]  

  • 11. Sucralfate and other non-antisecretory agents in the treatment of peptic ulcer disease.
    May B
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():113-6. PubMed ID: 2657280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dose, short duration therapy for the eradication of Helicobacter pylori in patients with duodenal ulcer.
    Iser JH; Buttigieg RJ; Iseli A
    Med J Aust; 1994 Feb; 160(4):192-6. PubMed ID: 7906009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does smoking predispose to peptic ulcer relapse after eradication of Helicobacter pylori?
    Chan FK; Sung JJ; Lee YT; Leung WK; Chan LY; Yung MY; Chung SC
    Am J Gastroenterol; 1997 Mar; 92(3):442-5. PubMed ID: 9068465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cure of duodenal ulcer after eradication of Helicobacter pylori.
    George LL; Borody TJ; Andrews P; Devine M; Moore-Jones D; Walton M; Brandl S
    Med J Aust; 1990 Aug; 153(3):145-9. PubMed ID: 1974027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical indications and efficacy of colloidal bismuth subcitrate.
    Lambert JR
    Scand J Gastroenterol Suppl; 1991; 185():13-21. PubMed ID: 1957121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Supraselective vagotomy. Long-term results in the treatment of duodenal ulcer].
    de Mestier P; Vallot T
    Presse Med; 1992 Jun; 21(22):1014-6. PubMed ID: 1354868
    [No Abstract]   [Full Text] [Related]  

  • 17. Refractory duodenal ulcer healing and relapse: comparison of omeprazole with Helicobacter pylori eradication.
    Avsar E; Kalayci C; Tözün N; Lawrence R; Kiziltas S; Gültekin O; Ulusoy NB
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):449-52. PubMed ID: 8804873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sucralfate maintenance therapy in duodenal ulcer disease. A review.
    Bolin TD
    Am J Med; 1989 Jun; 86(6A):148-51. PubMed ID: 2567571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of duodenal ulcer recurrence.
    Strum WB
    Ann Intern Med; 1986 Nov; 105(5):757-61. PubMed ID: 2876669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.